ISTA's Bepreve™ Receives FDA Approval for Allergic Conjunctivitis
Links shared publicly online about this topic.
- 1,743total visits
ISTA's Bepreve™ Receives FDA Approval for Allergic Conjunctivitis
View full resource at eyedocnews.com
Tags: Allergies, Eye Allergy, Eye, Eye Infection, Conjunctivitis, Drug, Pharma, FDA
Most Recently Shared on September 17, 2009 at 9:36 am By:
Discuss: ISTA Pharmaceuticals’ Bepreve™ Receives FDA Approval For Ocular Itching Associated With Allergi.. http://bit.ly/2mdVSi
HealthPack to Feature Expanded Standards Update | Pharmaceutical & Medical Packaging News
pmpnews.com — “Speakers at the upcoming HealthPack event March 6-8 in Albuquerque will update attendees on industry-specific AAMI, ISO, ASTM, and ISTA standards.” View full resource at pmpnews.com
Most Recently Shared on February 6, 2012 at 7:13 pm By:
Daphne Allen Health Communicator
Curious about ISO 11607 and ISO 16775? Visit HealthPack for an expanded standards update http://t.co/n2FxMArU
ISTA Pharmaceuticals, Inc. Initiates Phase 2 Clinical Study of... - Topix
topix.com — “ISTA Pharmaceuticals, Inc. Initiates Phase 2 Clinical Study of... - Topix” View full resource at topix.com
Most Recently Shared on January 5, 2012 at 10:26 pm By:
Allergy Bloggers Health News Feed
ISTA Pharmaceuticals, Inc. Initiates Phase 2 Clinical Study of...: http://t.co/tpH2iOG2
PROLENSA eye drops for cataract surgery patients
eyedocnews.com — “ISTA reports results of studies” View full resource at eyedocnews.com
Most Recently Shared on October 18, 2011 at 11:46 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: ISTA Pharmaceuticals Announces Phase 3 Results for PROLENSA(TM) Eye Drops for Treatment of Pain and Inf... http://t.co/jBS48JJZ
REMURA(TM) Eye Drops to Treat Dry Eye
eyedocnews.com — “ISTA reports on study of new eye drops for treatment of dry eye” View full resource at eyedocnews.com
Most Recently Shared on October 18, 2011 at 9:42 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: ISTA Pharmaceuticals Reports Results of Studies of REMURA(TM) Eye Drops for Dry Eye Disease: Last week,... http://t.co/m0tqJtjR
Getting More Nurses in School - Mineola, NY Patch
mineola.patch.com — “Rep. Carolyn McCarthy introduces legislation to increase number of nurses in school buildings.” View full resource at mineola.patch.com
Most Recently Shared on June 20, 2011 at 1:22 pm By:
NASN, Inc. Health Organization
Getting More Nurses in School - Mineola, http://t.co/F2IsTa0
Ista posts net loss for first quarter
osnsupersite.com — “IRVINE, Calif. — Ista Pharmaceuticals reported a net loss $84.1 million, or $2.49 per basic and diluted share, for the first quarter, accor” View full resource at osnsupersite.com
Most Recently Shared on May 18, 2011 at 6:05 pm By:
#Ista posts net loss for first quarter: http://ht.ly/4Xr2p
ISTA Pharmaceuticals Highlights BEPREVE Clinical Data at the 2011 American - Drugs.com MedNews
drugs.com — “Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting From Market Wire (March 22, 2011) ISTA Pharmaceuticals, Inc. (NASDAQ ISTA), today announced add” View full resource at drugs.com
Most Recently Shared on March 22, 2011 at 8:23 pm By:
Drugs and Devices OW OW Health
ISTA Pharmaceuticals Highlights BEPREVE Clinical Data at the 2011 American: Academy of Allergy, Asthma and... http://bit.ly/h0JoHr #drug
Ista Pharmaceuticals to discontinue twice-daily bromfenac in favor of once-daily formulation
osnsupersite.com — “IRVINE, Calif. — Ista Pharmaceuticals has announced plans to discontinue all shipments of twice-daily bromfenac ophthalmic solution 0.09% o” View full resource at osnsupersite.com
Most Recently Shared on February 8, 2011 at 4:12 pm By:
Ista Pharmaceuticals to discontinue twice-daily bromfenac in favor of once-daily formulation: http://ht.ly/3Sudg — #ophthalmology #business
Bausch and Lomb and Ista continue to give samples
eyedocnews.com — “Alcon and Allergan no longer giving samples” View full resource at eyedocnews.com
Most Recently Shared on February 3, 2011 at 9:34 am By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: Bausch and Lomb and Ista Drug Reps Only Ones Left Giving Samples: What gives? Alcon and Allergan have s... http://bit.ly/fkURDQ
Win a book :: Alpine Weight Loss Secrets
alpineweightlosssecrets.com — “Enter to win your free book, it's easy! Twitter: Log in to your Twitter account. Update your status with the following Tweet: Hey @iSta” View full resource at alpineweightlosssecrets.com
Most Recently Shared on January 31, 2011 at 11:34 pm By:
Stefan Aschan S123 Fitness Enthusiast and Wellness Coach
Congratulations Penny Frey. You won a free book of the Alpine Weight Loss Secrets .... http://ow.ly/3NH3G
ISTA Begins Phase 2 Allergy Trial
dddmag.com — “ISTA Pharmaceuticals, Inc. announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies.” View full resource at dddmag.com
Most Recently Shared on December 15, 2010 at 5:17 pm By:
ISTA Begins Phase 2 Allergy Trial http://bit.ly/fXEpuT
ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray... -- IRVINE, Calif., Dec. 14, 2010 /PRNewswire/ --
prnewswire.com — “ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis.” View full resource at prnewswire.com
Most Recently Shared on December 14, 2010 at 12:50 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
ISTA Pharmaceuticals Initiates Phase 2 Clinical Study of Bepotastine Besilate Nasal Spray... -- IRVINE, Calif.--: http://is.gd/iJdDv
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery - - Drug Topics
drugtopics.modernmedicine.com — “Bromfenac ophthalmic solution (Bromday, ISTA Pharmaceuticals) 0.09% has been granted FDA approval as a once-daily prescription eyedrop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 21, 2010 at 2:27 pm By:
Drugs and Devices OW OW Health
Breaking news: FDA approves first once-daily eyedrop for inflammation and pain after cataract surgery: Br... http://bit.ly/cO6qbt #drug
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 1:08 am By:
ISTA Pharmaceuticals Receives FDA Approval for Bromday - http://bit.ly/9KROwW
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 12:10 am By:
Drugs and Devices OW OW Health
ISTA Pharmaceuticals Receives FDA Approval for Bromday: IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- IST... http://bit.ly/a2xJ9h #drug
Advertisement
